| Mixed Ligand Copper(II) Complexes of N,N-Bis(benzimidazol-2-ylmethyl)amine (BBA) with Diimine Co-Ligands: Efficient Chemical Nuclease and Protease … R Loganathan, S Ramakrishnan, E Suresh, A Riyasdeen, MA Akbarsha, ... Inorganic chemistry 51 (10), 5512-5532, 2012 | 230 | 2012 |
| New ruthenium (II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and … M Ganeshpandian, R Loganathan, E Suresh, A Riyasdeen, MA Akbarsha, ... Dalton Transactions 43 (3), 1203-1219, 2014 | 202 | 2014 |
| Interaction of mixed ligand copper (II) complexes with CT DNA and BSA: Effect of primary ligand hydrophobicity on DNA and protein binding and cleavage and anticancer activities M Ganeshpandian, R Loganathan, S Ramakrishnan, A Riyasdeen, ... Polyhedron 52, 924-938, 2013 | 114 | 2013 |
| Copper (II) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities C Rajarajeswari, R Loganathan, M Palaniandavar, E Suresh, ... Dalton Transactions 42 (23), 8347-8363, 2013 | 112 | 2013 |
| Mixed ligand μ-phenoxo-bridged dinuclear copper (II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity R Loganathan, S Ramakrishnan, E Suresh, M Palaniandavar, ... Dalton Transactions 43 (16), 6177-6194, 2014 | 108 | 2014 |
| FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer EA Orellana, S Tenneti, L Rangasamy, LT Lyle, PS Low, AL Kasinski Science translational medicine 9 (401), eaam9327, 2017 | 88 | 2017 |
| DNA and protein binding, double-strand DNA cleavage and cytotoxicity of mixed ligand copper (II) complexes of the antibacterial drug nalidixic acid R Loganathan, M Ganeshpandian, NSP Bhuvanesh, M Palaniandavar, ... Journal of inorganic biochemistry 174, 1-13, 2017 | 77 | 2017 |
| Mixed ligand copper (II) dicarboxylate complexes: the role of co-ligand hydrophobicity in DNA binding, double-strand DNA cleavage, protein binding and cytotoxicity R Loganathan, S Ramakrishnan, M Ganeshpandian, NSP Bhuvanesh, ... Dalton Transactions 44 (22), 10210-10227, 2015 | 62 | 2015 |
| Synthesis, characterization and biological evaluation of novel Ru (II)–arene complexes containing intercalating ligands S Nikolić, L Rangasamy, N Gligorijević, S Aranđelović, S Radulović, ... Journal of Inorganic Biochemistry 160, 156-165, 2016 | 50 | 2016 |
| Molecular Imaging Probes based on Matrix Metalloproteinase Inhibitors (MMPIs) R. Loganathan, D. G. Bruno, O. Irene, C. Claire, J. M. Zapico, A. Ramos and ... Molecules 24, 2982, 2019 | 44* | 2019 |
| Water soluble Ru (ii)–arene complexes of the antidiabetic drug metformin: DNA and protein binding, molecular docking, cytotoxicity and apoptosis-inducing activity D Gopalakrishnan, M Ganeshpandian, R Loganathan, NSP Bhuvanesh, ... RSC advances 7 (60), 37706-37719, 2017 | 40 | 2017 |
| Enhancing microRNA activity through increased endosomal release mediated by nigericin EA Orellana, AM Abdelaal, L Rangasamy, S Tenneti, S Myoung, PS Low, ... Molecular Therapy-Nucleic Acids 16, 505-518, 2019 | 30 | 2019 |
| New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K+/H+ Exchange L Rangasamy, V Chelvam, AK Kanduluru, M Srinivasarao, NA Bandara, ... Bioconjugate chemistry 29 (4), 1047-1059, 2018 | 28 | 2018 |
| Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics A Jaisankar, S Krishnan, L Rangasamy Analytical Biochemistry 655, 114874, 2022 | 25 | 2022 |
| Can 3D-printed bioactive glasses be the future of bone tissue engineering? A Dukle, D Murugan, AJ Nathanael, L Rangasamy, TH Oh Polymers 14 (8), 1627, 2022 | 23 | 2022 |
| Organometallic derivatization of the nematocidal drug monepantel leads to promising antiparasitic drug candidates J Hess, M Patra, L Rangasamy, S Konatschnig, O Blacque, A Jabbar, ... Chemistry–A European Journal 22 (46), 16602-16612, 2016 | 21 | 2016 |
| New dual CK2/HDAC1 inhibitors with nanomolar inhibitory activity against both enzymes L Rangasamy, I Ortín, JM Zapico, C Coderch, A Ramos, ... ACS Medicinal Chemistry Letters 11 (5), 713-719, 2020 | 15 | 2020 |
| Nanoparticle enhancement of natural killer (NK) cell-based immunotherapy D Murugan, V Murugesan, B Panchapakesan, L Rangasamy Cancers 14 (21), 5438, 2022 | 11 | 2022 |
| Mixed ligand copper (II)-diimine complexes of 2-formylpyridine-N 4-phenylthiosemicarbazone: Diimine co-ligands tune the in vitro nanomolar cytotoxicity R Kartikeyan, D Murugan, T Ajaykamal, M Varadhan, L Rangasamy, ... Dalton Transactions 52 (26), 9148-9169, 2023 | 9 | 2023 |
| The use of antimicrobial biomaterials as a savior from post-operative vascular graft-related infections: A review D Murugan, L Rangasamy Results in Engineering 16, 100662, 2022 | 9 | 2022 |
